Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: EU Member States national medicines agencies | Statement: [Heads of Medicines Agencies, membership, EU Member States national medicines agencies]

Target entity: EU Member States national medicines agencies
Context triple: [Heads of Medicines Agencies, membership, EU Member States national medicines agencies]

• A. European Medicines Agency
  The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
• B. European Directorate for the Quality of Medicines & HealthCare
  The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
• C. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• D. Heads of Medicines Agencies
  Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
• E. Committee for Herbal Medicinal Products
  The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: EU Member States national medicines agencies
Triple: [Heads of Medicines Agencies, membership, EU Member States national medicines agencies]

EU Member States national medicines agencies are the national regulatory authorities in each EU country responsible for evaluating, authorizing, and monitoring medicines within their jurisdictions.

Target entity: EU Member States national medicines agencies
Target entity description: EU Member States national medicines agencies are the national regulatory authorities in each EU country responsible for evaluating, authorizing, and monitoring medicines within their jurisdictions.

• A. European Medicines Agency
  The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
• B. European Directorate for the Quality of Medicines & HealthCare
  The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
• C. Committee for Proprietary Medicinal Products
  The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
• D. Heads of Medicines Agencies chosen
  Heads of Medicines Agencies is a European network of national medicines regulatory authorities that collaborates to coordinate and harmonize the regulation of medicinal products across EU and EEA member states.
• E. Committee for Herbal Medicinal Products
  The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
• F. None of above.